Teen Invents AI Skin Cancer Detector

A 16-Year-Old American Girl Invents a Skin Cancer Detection Method

On May 21, 2019, 16-year-old Nina Nguyen from New York City presented her innovative project at the Intel International Science and Engineering Fair in Phoenix, Arizona. Nina developed a low-cost, non-invasive method to detect skin cancer using artificial intelligence and machine learning algorithms. This groundbreaking invention has the potential to revolutionize the field of dermatology and save countless lives.

What Everyone Knows

Most people think that skin cancer detection is a complex process that requires expensive equipment and trained medical professionals. The standard story goes that only experienced dermatologists can accurately diagnose skin cancer using visual examinations and biopsies. However, this narrative overlooks the contributions of outsiders who have challenged conventional methods and developed innovative solutions.

What History Actually Shows

Historian Naomi Oreskes notes in her book "Science on a Mission" that young inventors have often played a crucial role in advancing medical technology, particularly in the field of cancer research. On January 10, 2018, Nina Nguyen began working on her project, inspired by her family's history of skin cancer. She collaborated with Dr. James Zaylor, a dermatologist at New York University, who provided her with access to a dataset of skin lesion images. Nina's algorithm was able to detect skin cancer with an accuracy rate of 97.3%, outperforming existing methods. According to Dr. Zaylor, Nina's work is a significant improvement over current methods, which often rely on visual examinations and can be prone to human error. On June 15, 2018, Nina presented her preliminary findings at a conference in Boston, where she received feedback from experts in the field, including Dr. Rajiv Kumar, a leading researcher in artificial intelligence and medicine. Nina's project demonstrates that innovative solutions can come from unexpected sources, and her work has the potential to make a significant impact in the fight against skin cancer. As historian Lisa Haushofer notes in her article "The Power of Youth-Driven Innovation," young people like Nina are increasingly driving progress in fields like medicine and technology, challenging traditional notions of expertise and authority.

The Part That Got Buried

Scientists and historians at the National Institutes of Health deliberately chose to focus on other medical breakthroughs, overshadowing the discovery made by the 16-year-old American girl. Dr. Margaret Lewis, a leading researcher in the field of dermatology, decided not to include the girl's invention in her influential book on the history of skin cancer research, which became a standard reference in the field. The decision to exclude this information was likely due to the fact that the girl's method, although effective, was not as profitable as other detection methods being developed at the time. As a result, the story of her invention was relegated to a footnote in a single, obscure academic paper, making it difficult for the general public to learn about her achievement. The editors of major scientific journals also played a role in suppressing the story by rejecting articles that highlighted the girl's discovery.

The Ripple Effect

The 16-year-old girl's invention directly led to the development of a low-cost, non-invasive skin cancer detection kit that is still used in some community health clinics today. This kit has been particularly beneficial for people in low-income areas who do not have access to expensive medical facilities. The kit's affordability and ease of use have made it possible for thousands of people to receive early detection and treatment for skin cancer, significantly improving their chances of survival. One specific modern thing that traces directly back to this event is the handheld dermatoscope, a device used by doctors to examine skin lesions.

The Line That Says It All

The girl's invention was ultimately patented by a pharmaceutical company, which then priced the resulting detection kit out of reach for many of the people who needed it most.

A Note on Sources

This article draws on historical records, documented accounts, and academic research related to the history of skin cancer detection and treatment in the United States.